Financial Performance - The company's revenue for Q1 2021 was ¥139,064,824.26, a decrease of 22.10% compared to ¥178,521,545.80 in the same period last year[9] - Net profit attributable to shareholders was ¥30,799,153.39, down 57.43% from ¥72,345,807.65 year-on-year[9] - Basic earnings per share decreased to ¥0.70, down 57.58% from ¥1.65 in the same period last year[9] - The company's net profit for Q1 2021 was CNY 30,833,493.13, down from CNY 72,345,807.65 in Q1 2020, representing a decline of 57.3%[41] - The total comprehensive income for Q1 2021 was CNY 30,833,493.13, significantly lower than CNY 72,345,807.65 in Q1 2020, indicating a decline of 57.3%[41] - The total operating profit for Q1 2021 was CNY 30,842,969.01, down from CNY 73,865,216.08 in Q1 2020, reflecting a decline of 58.3%[44] - The company reported a gross profit margin of approximately 22.5% for Q1 2021, down from 36.9% in Q1 2020, indicating a decline in profitability[43] Cash Flow - The net cash flow from operating activities was ¥9,220,734.28, representing a significant decline of 88.50% compared to ¥80,158,178.84 in the previous year[9] - The cash flow from operating activities for Q1 2021 was CNY 9,220,734.28, a substantial decrease from CNY 80,158,178.84 in the same period last year[48] - Total cash inflow from investing activities was ¥17,633,000.00, while cash outflow was ¥4,966,212.54, resulting in a net cash flow of ¥12,666,787.46, compared to a negative cash flow of ¥11,155,728.73 in the previous year[51] - The company reported a total cash inflow from financing activities of ¥128,800,000.00, with cash outflow of ¥40,173,000.01, leading to a net cash flow of -¥40,173,000.01, compared to -¥1,116,329.12 in the previous year[52] - The ending balance of cash and cash equivalents was ¥3,778,347.45, a significant decrease from ¥38,765,850.68 in the same period last year[52] - The company’s cash and cash equivalents decreased by ¥8,992,161.86 during the quarter, compared to an increase of ¥33,656,395.04 in the same period last year[52] Assets and Liabilities - Total assets at the end of the reporting period were ¥1,160,414,284.53, a slight decrease of 0.36% from ¥1,164,722,157.98 at the end of the previous year[9] - The company's total assets as of March 31, 2021, were CNY 699,767,520.01, down from CNY 718,422,385.54 at the end of 2020[35] - The total liabilities decreased to CNY 209,392,332.38 from CNY 240,831,285.16, showing a reduction of approximately 13%[36] - The company's net assets attributable to shareholders increased by 3.61% to ¥878,483,672.62 from ¥847,838,098.33 at the end of the previous year[9] Receivables and Payables - Accounts receivable increased by 75.53% to ¥27,265,577.18 due to the addition of new customers[17] - The balance of other receivables rose by 241.38% to ¥802,358.30, primarily due to an increase in receivable interest[17] - Employee compensation payable at the end of the reporting period was ¥6,244,062.69, a decrease of 67.44% compared to the beginning of the year, mainly due to the payment of the 2020 year-end bonus in the first quarter[18] - Tax payable at the end of the reporting period was ¥87,398.93, a decrease of 61.34% compared to the beginning of the year, primarily due to the payment of taxes accrued at the beginning of the year in the first quarter[18] Expenses - Sales expenses for the first quarter of 2021 amounted to ¥1,521,677.93, an increase of 88.58% year-on-year, attributed to the increase in the number of sales offices and personnel[19] - Management expenses for the first quarter of 2021 were ¥1,847,871.93, a decrease of 65.83% year-on-year, due to cost control measures implemented by the company[19] - Financial expenses for the first quarter of 2021 were -¥1,821,284.33, a decrease of 919.96% year-on-year, mainly due to increased interest income[19] - Other income for the first quarter of 2021 was ¥3,614,192.31, an increase of 49.51% year-on-year, primarily due to higher government subsidies received[19] - Cash paid for purchasing goods and services in the first quarter of 2021 was ¥81,344,269.89, an increase of 36.62% year-on-year, due to increased material procurement for new production bases[19] - Cash received from investment income in the first quarter of 2021 was ¥79,996.87, a decrease of 77.36% year-on-year, due to reduced financial income compared to the previous year[19] Research and Development - Research and development expenses for Q1 2021 were CNY 1,554,727.72, slightly lower than CNY 1,769,929.01 in the previous year[43] Asset Disposal - The company incurred a loss of CNY 8,411.75 from asset disposal in Q1 2021, compared to a loss of CNY 108,782.56 in the same period last year[44] Accounting Policies - The company did not adjust the balance sheet items at the beginning of the year under the new leasing standards, indicating no significant changes in accounting policies[53]
华绿生物(300970) - 2021 Q1 - 季度财报